Pharming Group N.V.

NASDAQ: PHAR · Real-Time Price · USD
11.75
0.37 (3.25%)
At close: Aug 15, 2025, 3:50 PM
11.60
-1.28%
After-hours: Aug 15, 2025, 05:26 PM EDT

Pharming Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Aug 5, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
94.37M 79.09M 92.67M 75.06M 74.03M 55.59M 81.87M 66.66M 54.9M 42.54M 54.62M 54.24M 50.15M 46.62M 45.75M 49.44M 49.74M 42.25M
Cost of Revenue
9.11M 8.32M 12.21M 6.82M 7.99M 8.37M 14.78M 8.29M 5.72M 4.08M 6.27M 2.38M 4.03M 4.88M 4.89M 5.64M 4.66M 4.7M
Gross Profit
85.26M 70.77M 80.46M 68.03M 66.04M 47.09M 67.09M 58.37M 49.17M 38.47M 48.35M 51.86M 46.12M 41.74M 40.86M 43.79M 45.08M 37.55M
Operating Income
11.24M -7.04M 6.7M 4.11M -4M -16.31M 604.93K 1.91M 5.3M -13.66M -10.18M 10.53M 17.82M 5.61M -1.36M -2.08M 10.83M 6.09M
Interest Income
n/a 604K 1.1M 825K 920K 1.78M 1.61M 1.88M 676K 123K -4.92M 9.3M -3.28M 3.23M 4.3M 4.26M n/a 8.16M
Pretax Income
7.19M -11.79M 6.68M 1.51M 299.72K -16.62M -2.72M 3.31M 3.39M -16.67M -18.08M 9.28M 19.56M 4.23M 1.64M 906.94K 7.35M 12.41M
Net Income
4.66M -14.72M 2.86M -1.03M -1.2M -12.42M -2.72M 3.46M 1.32M -12.21M -14.63M 9.1M 15.74M 3.46M 1.86M -673.87K 5.89M 8.52M
Selling & General & Admin
50.23M 57.06M 48.58M 43.98M 48.45M 45.23M 54.79M 35.82M 44.89M 37.09M 46.55M 32.4M 27.95M 24.93M 25.89M 21.1M 21.83M 21.33M
Research & Development
23.8M 21.14M 22.14M 20.72M 21.58M 18.48M 11.7M 20.65M 20.89M 15.62M 10.89M 12.34M 14.43M 14.86M 17.03M 25.18M 13.51M 10.38M
Other Expenses
n/a -383K n/a -777K n/a -345K n/a -304K -21.93M -579K 1.08M -647K -14.08M -873K -701K -386K -909K -214K
Operating Expenses
74.02M 77.81M 73.75M 63.92M 70.03M 63.71M 66.49M 56.46M 43.87M 52.13M 58.52M 44.09M 28.3M 38.91M 42.22M 45.87M 34.25M 31.46M
Interest Expense
4.76M 5.1M 2.48M 3M 1.97M 1.56M 1.34M 1.65M 174K 2.79M 1.38M 1.25M 1.35M 1.38M 1.5M 1.4M 1.29M 1.6M
Selling & Marketing Expenses
n/a 34.57M -84.73M 28.69M 32.93M 30.25M -79.32M 25.12M 33.91M 27.11M 28.98M 20.37M 19.25M 17.2M 13.5M 14.17M 13.91M 14.39M
Cost & Expenses
83.13M 86.14M 85.97M 70.74M 78.03M 71.9M 81.26M 64.75M 49.6M 56.2M 64.8M 46.47M 32.33M 43.79M 47.11M 51.52M 38.91M 36.16M
Income Tax Expense
2.53M 3.1M 3.82M 2.55M 1.1M -4.17M 705.75K -157K 2.07M -4.47M -3.45M 178K 3.81M 772K -217K 1.58M 1.46M 4.14M
Shares Outstanding (Basic)
66.9M 66.9M 68.03M 64.63M 84.79M 83.88M 83.88M 82.04M 65.92M 82.04M 82.04M 83.05M 86.53M 86.53M 80.25M 79.76M 80.13M 79.76M
Shares Outstanding (Diluted)
66.9M 66.9M 68.03M 64.63M 84.79M 83.88M 83.88M 82.04M 65.92M 82.04M 82.04M 86.53M 86.53M 86.53M 87.64M 80.13M 80.13M 81.95M
EPS (Basic)
0.07 -0.22 0.05 -0.02 -0.01 -0.15 -0.03 0.05 0.02 -0.15 -0.18 0.11 0.18 0.04 0.02 -0.01 0.06 0.10
EPS (Diluted)
0.07 -0.22 0.05 -0.02 -0.01 -0.15 -0.03 0.05 0.02 -0.15 -0.18 0.10 0.18 0.04 0.02 -0.01 0.06 0.10
EBITDA
11.64M -4.11M 15.63M 7.25M -4.28M -9.15M 6.87M 4.81M 6.72M -11.57M -10.34M 12.48M 22.98M 7.8M 13.9M 4.49M 11.18M 16.45M
EBIT
11.64M -6.69M 7.93M 4.51M 1.91M -15.07M -688K 1.91M 3.56M -13.88M -16.7M 10.53M 20.91M 5.61M 4.18M 2.31M 8.72M 14.39M
Depreciation & Amortization
n/a 2.58M 7.7M 2.75M -293K 5.92M 7.55M 2.9M 3.16M 2.31M 6.97M 1.95M 2.07M 2.19M 12.96M 2.19M 2.46M 2.06M